Skip to main content
Premium Trial:

Request an Annual Quote

Biochip Maker Randox Adds Sądecki Bartnik to List of Euro Food Diagnostics Clients

Premium

Randox Food Diagnostics said this week that Sądecki Bartnik, a major Polish honey producer, has adopted its biochip array technology for antibiotic screening.

According to Randox, Sądecki Bartnik is the third European honey maker to move to its platform. France's Lune de Miel and Germany's Langnesse decided to adopt Randox's technology two years ago.

Aaron Tohill, manager of Randox's Food Diagnostics business, said in a statement that the agreement "strengthens [Randox's] position within the continental and global marketplace." He also noted that Randox's products are being adopted at a time when "EU rapid alerts [are] showing regular issues surrounding antimicrobials within the region."

As part of the deal, Sądecki Bartnik will obtain two of Randox's Evidence Investigator Analyzers and a supply of antimicrobial testing kits. The new tools will be used at Sądecki Bartnik's main production sites in Poland and Ukraine. Sądecki Bartnik previously used microtiter-plate-based receptor binding assays to screen its products, Randox said.

Randox continues to build a menu of arrays for food producers. Earlier this month, the company launched a test for coccidiostats in poultry meat and eggs (BAN 10/1/2013). Last year, it introduced an assay to test livestock for the presence of antiparasitic drugs (BAN 10/9/2012).

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.